Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19

Current formulations and dose regimens of hydroxychloroquine (HCQ) put patients at risk of harm. An analysis of clinical trials registered on ClinicalTrials.gov revealed that this may continue as many studies combine HCQ with agents that prolong the QT interval. Further, almost all of the trials reg...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Med Hypotheses
Main Authors: Kavanagh, Oisín, Marie Healy, Anne, Dayton, Francis, Robinson, Shane, O'Reilly, Niall J., Mahoney, Brian, Arthur, Aisling, Walker, Gavin, Farragher, John P.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier Ltd. 2020
Fag:
Letter to Editors
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361049/
https://ncbi.nlm.nih.gov/pubmed/33017904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.110110
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker